Home

A Consistent Standard for Dust Safety
The adoption of the National Fire Protection Association’s unified standard for combustible dusts and particulate solids, NFPA 660, marks an important evolution in combustible dust safety. Rather than introducing an entirely new philosophy, NFPA 660 consolidates several legacy combustible dust standards into one comprehensive document, providing a consistent framework for evaluating combustible dust hazards across all industries. read more
Can OSD Handle the GLP-1 Appetite?
The injectable weight-loss drug boom didn’t just strain drugmakers with approved products, it reshaped the entire pharma ecosystem, forcing suppliers and manufacturers to reorganize around GLP-1s. read more
Oral Solid Dose Regulatory Approval Update
CDER has approved 33 novel drugs so far, almost half of which are oral solid dose formulations. read more
Root Cause Analysis of Tablet Manufacturing Issues
Many formulation challenges such as poor flow, segregation, capping and weak tablets can be traced to suboptimal micromeritics properties. read more

Elevar Wins FDA Approval for Oral Bile Duct Cancer Drug
September 28, 2026
The potent oral small molecule inhibitor uses selective targeting of FGFR2 to minimize off-isoform toxicities. read more
Merck to License SciBrunch Cancer Drug in Potential $2.13B Deal
September 28, 2026
The potent KRAS G12D (ON) inhibitor targets the most common RAS mutation in human cancers while being selective over KRAS wildtype cells. read more
J&J Shares Positive Phase 3 Results for Oral Bipolar Drug
September 28, 2026
The drug, which is already approved for treating bipolar depression, demonstrated efficacy for reducing signs and symptoms of mania. read more